AKAnika Kreutzberg

Anika Kreutzberg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anika Kreutzberg has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparative predictive performance of the PopGrouper: internal validation of a population-based classification system for morbidity adjustment using German administrative data

    by Anika Kreutzberg, Chrissa Tsatsaronis, Wilm Quentin, Reinhard Busse

    Background: To compare the predictive performance of a newly developed population classification system, the PopGrouper, with established morbidity measures used in administrative data research for 1-year mortality, hospitalisation, and healthcare costs. Methods: This study presents an internal validation using an independent hold-out sample derived from 2022 to 2023 claims data from BARMER, a large German statutory health insurer covering about 10% of the national population (> 8 million). All adults (≥ 18 years) continuously insured in 2022–2023 or deceased in 2023 were included of which a 20%-random sample ( n = 1,310,273) was used as validation cohort. Regression models were estimated for different outcomes, using age-sex groups, the Charlson Comorbidity Index, Elixhauser comorbidities, PopGroup severity quintiles, Macro PopGroups, or PopGroups as morbidity adjustment methods. For mortality and hospitalisation, sparsely populated PopGroups were hierarchically aggregated to ensure a minimum number of events per group. Predictive performance was assessed using the coefficient of determination (R²) and root mean square error (RMSE) for log-transformed cost outcomes, and c-statistics for mortality and hospitalisation, based on 1,000 bootstrap samples. Results: The PopGroup model explained 35.8% of the variation in log-transformed total healthcare costs, compared with 11.5% for age-sex groups, 13.2% for Charlson, and 18.6% for Elixhauser. Discrimination for mortality was excellent (c-statistic = 0.884 [95% CI: 0.882–0.886]) and acceptable for hospitalisation (0.714 [0.712–0.715]). Differences compared with conventional morbidity measures were most pronounced for healthcare cost prediction, whereas gains for mortality and hospitalisation discrimination were smaller. Sensitivity analyses yielded consistent findings, confirming robustness across model specifications. Conclusions: The PopGrouper is an open and reproducible classification system which captures multimorbidity by building clinically and economically meaningful groups derived from administrative data. In this internal validation, it demonstrated strong performance across both clinical and economic outcomes, with the largest improvements observed for healthcare cost prediction. The PopGrouper may therefore provide a useful alternative tool for morbidity adjustment, particularly in applications involving healthcare planning, resource allocation, and population health management.

  • Open Access

    Regional variation in all-cause mortality among breast cancer patients in Germany: an analysis using the PopGrouper

    by Chrissa Tsatsaronis, Anika Kreutzberg, Reinhard Busse, Wilm Quentin

    Background: Breast cancer is the most common cancer among women in Germany. Although improvements in early detection and treatment have improved survival, differences in patient morbidity and healthcare delivery may contribute to regional variation in outcomes. All-cause mortality provides a measure that captures deaths related to both breast cancer and comorbid conditions. This study examines regional variation in all-cause mortality among breast cancer patients in Germany, using the PopGrouper as a novel morbidity adjustment tool. Methods: Claims data from the BARMER sickness fund for 2022–2023 were analyzed for actively treated breast cancer patients ( n = 28,446). First, PopGroup-standardized observed-to-expected (O/E) ratios were calculated to describe regional variation of all-cause mortality in 2023, compared to the national average. Subsequently, the PopGrouper was used in multilevel regression analyses to analyze the association between age, morbidity, and all-cause mortality. Results: After PopGroup-standardization, O/E mortality ratios ranged between 0.4 and 2.0 between regions (coefficient of variation = 20%). The regression analysis did not confirm statistically significant differences in mortality between regions, but between age and morbidity groups. Conclusion: The PopGrouper can be used both for indirect standardization as in the O/E analyses and in regression models. Comparing both approaches can provide complementary perspectives and a more comprehensive assessment of regional variation. The PopGrouper represents a valuable tool for adjusting for morbidity-related care needs in regional comparative analyses.

  • Open Access

    Regional variation in healthcare utilization among patients with depression in Germany: a multilevel analysis with PopGrouper-based multimorbidity adjustment

    by Anika Kreutzberg, Chrissa Tsatsaronis, Wilm Quentin, Reinhard Busse

    Background: Depression is associated with a substantial health and economic burden and shows pronounced regional variation in Germany. While socioeconomic and urban–rural differences in depression prevalence and service use are well documented, less is known about how regional socioeconomic deprivation and urbanization relate to healthcare utilization after accounting for multimorbidity. Methods: We analyzed nationwide claims data from a large German sickness fund including adults with diagnosed depression ( N = 1,083,319). Healthcare utilization in 2023 was measured as healthcare costs, days of sickness absence, any outpatient mental health specialist contact, and outpatient psychotherapy use. Multilevel regression models with individuals nested within 96 spatial planning regions were estimated, adjusting for age, sex, and multimorbidity using the PopGrouper. Regional socioeconomic deprivation was measured using the German Index of Socioeconomic Deprivation, and urbanization was classified as urban, semi-urban, or rural. Proportional variance component analyses quantified explained regional heterogeneity. Results: Higher regional socioeconomic deprivation was significantly associated with more days of sickness absence (adjusted mean: 34.1 days in the least vs. 40.1 days in the most deprived regions) and a lower likelihood of receiving outpatient psychotherapy (17.9% vs. 16.3%). No significant associations were observed between deprivation and healthcare costs or mental health specialist contacts. Urban regions were associated with higher healthcare costs (2,284€ vs. 2,188€) and more frequent mental health specialist contacts (15.6% vs. 13.5%). Overall regional clustering was modest but most pronounced for mental health specialist contacts. Conclusion: Regional socioeconomic deprivation is linked to higher sickness absence due to depression. Regional inequalities in access to mental health services are small but largely unexplained by deprivation, urbanization, and multimorbidity.


  • Open Access

    The effects of waiting time for outpatient psychotherapeutic interventions on patient-reported outcomes in adolescents and adults with eating disorders: a systematic review and meta-analysis

    by Marike Kranes, Pauline S. Münchenberg, Carmen Thomas, Ricarda S. Schulz, Alessandro Campione, Anika Kreutzberg

    Objective: To assess the effects of waiting time for outpatient psychotherapeutic interventions on patient-reported outcomes in adolescents and adults with eating disorders. Method: MEDLINE, Embase, APA PsycInfo, CENTRAL and BASE were searched on 12 August 2025. Quantitative studies of adolescents (≥ 10 years) and adults with eating disorders that examined waitlist conditions prior to outpatient psychotherapeutic interventions and measured eating disorder pathology with the Children's Eating Attitudes Test (chEAT) or Eating Disorder Examination-Questionnaire (EDE-Q) were eligible. Risk of bias was assessed using the RoB 2 and ROBINS-I tools. A within-group random-effects meta-analysis was performed assessing pre–post change scores of the EDE-Q Global Score (primary analysis) and EDE-Q subscales (secondary analyses). A full protocol has been pre-registered on PROSPERO (registration number: CRD420251090691). Results: Nine waitlist-controlled studies (total n = 647, waitlisted n = 283) including adult participants with bulimia nervosa, binge-eating disorder and 'eating disorder not otherwise specified' met our eligibility criteria. Eight studies (waitlisted n = 273) were included in the meta-analysis. Participants entered the waiting period with high EDE-Q Global Scores, ranging from 3.08 to 4.65 across studies. The pooled pre–post effect estimate was Hedges’ g = − 0.17 (95% CI − 0.30 to − 0.05), indicating a negligible reduction in eating disorder pathology. Certainty of evidence was rated as moderate, given the high risk of bias across studies. Discussion: Based on our results, waiting in waitlist control groups represents a period during which substantial eating disorder pathology and associated distress persist without therapeutic intervention. Further research is needed to better understand the effects of waiting time for regular eating disorder treatment outside a study setting.

  • Open Access

    Regional variation in ambulatory care-sensitive hospitalizations for people with type 2 diabetes in Germany: insights from a claims data analysis using the PopGrouper

    by Chrissa Tsatsaronis, Anika Kreutzberg, Maria Klemt, Karen Kinder, Reinhard Busse, Wilm Quentin

    Background: Diabetes-related hospitalizations and amputations serve as indicators of healthcare system performance, revealing regional disparities in diabetes management. This study examines regional variations in diabetes-related and all-cause outcomes among people with type 2 diabetes across Germany, adjusting for morbidity using the novel PopGrouper classification system. The paper aims to test the applicability of the PopGrouper for analyses of regional variations in health care. Methods: Based on claims data from the BARMER sickness fund, six outcomes (hospitalizations, emergency hospitalizations, amputations, hospital care costs, inpatient days, and mortality) were analyzed. For each outcome, the ratio of observed to expected outcomes was calculated based on each region’s PopGroup composition and compared to results based on age-sex composition. Finally, the analysis identified top- and bottom-performing regions based on PopGroup-adjusted performance and explored patterns of resource utilization in these regions. Results: The findings reveal the greatest regional variation for amputations and emergency hospitalizations, followed by hospitalizations, for both, age-sex-standardized and PopGroup-standardized ratios. The observed variation was slightly lower with PopGroup standardization than with age-sex standardization, except in the case of mortality. The top-performing regions had lower inpatient resource utilization, but higher outpatient resource utilization and participation in disease management programs in the year prior to the performance outcome measurement. Conclusion: Regional variations in hospitalizations and related outcomes for type 2 diabetes were observed. The PopGrouper enables straightforward risk-adjustment through indirect standardization and can make a significant contribution to controlling for morbidity-related care needs in regional comparative analyses.


  • Open Access

    The PopGrouper as a tool for morbidity adjustment in regional comparisons of health care: an analytical framework

    by Anika Kreutzberg, Chrissa Tsatsaronis, Thomas G. Grobe, Wilm Quentin, Reinhard Busse, On behalf of the PopGroup consortium

    Background: Analyzing regional variations can help improve equity, efficiency, and quality in health care provision. The PopGrouper is a population-based classification system which classifies persons with similar health care needs into distinct groups. It exhibits a high degree of morbidity differentiation. We present an analytical framework to use the PopGrouper in examining regional variations across different outcomes and populations using routine patient-level data. Methods: We develop a two-step empirical strategy to examine the relative regional performance on a set of efficiency and quality outcomes (e.g., hospital bed days, cost of care, mortality). First, we propose PopGroup-standardized observed-to-expected ratios to compare regional performance. Second, we develop a multilevel regression model to separately estimate regional variation related to patient need measured by the PopGroup and variation related to regional characteristics. Results: We provide an analytical framework that demonstrates the PopGrouper’s application as a tool for morbidity adjustment in the assessment of relative regional performance in efficiency and quality outcomes and the regional characteristics that explain this performance. We provide suggestions for empirical notation, interpretation of results, and graphical analyses of findings. The developed framework will be applied in subsequent empirical papers. Conclusion: This paper sets the analytical foundations to be applied in regional comparative analyses using the PopGrouper allowing for conclusions about unexplained variations in quality and efficiency of health care.


  • Open Access

    International strategies, experiences, and payment models to incentivise day surgery

    by Anika Kreutzberg, Helene Eckhardt, Ricarda Milstein, Reinhard Busse


  • Open Access

    Improving access to services for psychotic patients: does implementing a waiting time target make a difference

    by Anika Kreutzberg, Rowena Jacobs

    Objective: In April 2015, the English National Health Service started implementing the first waiting time targets in mental health care. This study aims to investigate the effect of the 14-day waiting time target for early intervention in psychosis (EIP) services after the first six months of its implementation.Study design: We analyse a cohort of first-episode psychosis patients from the English administrative Mental Health and Learning Disabilities Dataset 2011 to 2015. We compare patients being treated by EIP services (treatment) with those receiving care from standard community mental health services (control). We combine non-parametric matching with a difference-in-difference approach to account for observed and unobserved group differences. We analyse the probability of waiting below target and look at different percentiles of the waiting time distribution.Results: EIP patients had an 11.6–18.4 percentage point higher chance of waiting below target post-policy compared to standard care patients. However, post-policy trends at different percentiles of the waiting time distribution were not different between groups.Conclusions: Mental health providers seem to respond to waiting time targets in a similar way as physical health providers. The increased proportion waiting below target did not, however, result in an overall improvement across the waiting time distribution.


  • Open Access

    The impact of waiting time on patient outcomes: Evidence from early intervention in psychosis services in England

    by Anika Reichert, Rowena Jacobs

    Recently, new emphasis was put on reducing waiting times in mental health services as there is an ongoing concern that longer waiting time for treatment leads to poorer health outcomes. However, little is known about delays within the mental health service system and its impact on patients. We explore the impact of waiting times on patient outcomes in the context of early intervention in psychosis (EIP) services in England from April 2012 to March 2015. We use the Mental Health Services Data Set and the routine outcome measure the Health of the Nation Outcome Scale. In a generalised linear regression model, we control for baseline outcomes, previous service use, and treatment intensity to account for possible endogeneity in waiting time. We find that longer waiting time is significantly associated with a deterioration in patient outcomes 12 months after acceptance for treatment for patients that are still in EIP care. Effects are strongest for waiting times longer than 3 months, and effect sizes are small to moderate. Patients with shorter treatment periods are not affected. The results suggest that policies should aim to reduce excessively long waits in order to improve outcomes for patients waiting for treatment for psychosis.